In development for more than a decade, the light adjustable intraocular lens (LALŪ; Calhoun Vision, Inc.) is approved for use in Europe and is in Phase III clinical trials in the United States. Based on clinical results and almost 4 years of commercial experience in Europe, the LAL has the potential to make the refractive [...]

More...